Register entry
- Registered sites
- 1
- Active NDC listings
- 0
- Live patents
- 81
- Exclusivities
- 2
- Countries
- 1
- Base
- Switzerland
Authorisation
Registered operations
Analytical testing1Labelling1Finished drug manufacture1Packaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| IBSA Institut Biochimique SA | Via Pian Scairolo 49, Pazzallo, Ticino CH - 6912, Switzerland (CHE) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3002864272480278696 |
Exclusivity
Patents and exclusivities
81| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 11123287 | VYBRIQUEsildenafil citrate | product | Dec 2033 |
| 11344520 | LICARTdiclofenac epolamine | use | Feb 2035 |
| 11351133 | LICARTdiclofenac epolamine | use | Feb 2035 |
| 10537538 | TIROSINT-SOLlevothyroxine sodium | product | Feb 2037 |
| 11096913 | TIROSINT-SOLlevothyroxine sodium | product | Feb 2037 |
| 11241382 | TIROSINT-SOLlevothyroxine sodium | use | Sept 2039 |
| 12564565 | TIROSINT, TIROSINT-SOLlevothyroxine sodium | product | Sept 2044 |
| Product | Exclusivity | Until |
|---|---|---|
| LICARTDICLOFENAC EPOLAMINE | NPP New patient population | Mar 2029 |
| VYBRIQUESILDENAFIL CITRATE | NP New product | Dec 2028 |
Compare
Comparable companies in Switzerland
- Ricola Ag1 site · 84 NDC
- Avyxa GmbH1 site · 29 NDC
- Bachem AG1 site · 23 NDC
- Vifor (International) AG1 site · 22 NDC
- DOTTIKON EXCLUSIVE SYNTHESIS AG1 site · 16 NDC
- HAS Healthcare Advanced Synthesis SA1 site · 11 NDC
- Cerbios-Pharma SA1 site · 9 NDC
- SINTETICA S.A.1 site · 9 NDC
- Similasan AG1 site · 7 NDC
- Swiss Caps AG1 site · 6 NDC
Enquiry
Common questions
- Is IBSA Institut Biochimique SA FDA approved?
- IBSA Institut Biochimique SA holds 1 FDA-registered establishment in Switzerland. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are IBSA Institut Biochimique SA's drugs manufactured?
- The FDA register lists Pazzallo. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.